Investing in Regulatory Industries The Qumas Story David Grimes Co-Founder and COO

1
Investing in Regulatory IndustriesThe Qumas
StoryDavid Grimes Co-Founder and COO
2
What does Qumas do?

• Qumas delivers Enterprise compliance software
  products for the life sciences sector

3
OUR VISION

• Deliver Value to our Shareholders, Employees and
  Clients in providing Solutions Designed to
  Seamlessly Integrate Regulatory Best Practices
  Across the Enterprise

4
OUR CULTURE

• Each Employee to beat best practices of
  Competition
• Innovation, Quality, Teamwork, Risk taking
• Training, information, communication
• Innovation! not Imitation
• Challenge traditional values , practices
  concepts to add value

5
OUR MOTTO

• Add Value or Die!
• If your not adding value stop now (seek/challenge
  objectives!)
• If your throwing away value your on life support

6
The Commercial Climate

• Uncharted waters seismic shifts in market
  dynamics
• Stock Market
• Life Sciences Under Pressure
• Globalization
• Deregulation
• Recession
• Competitor Chaos
• Opportunities! Opportunities! Opportunities!

7
Why Qumas Choose Life Sciences?

• Ability to pay
• Deep compliance need
• FDA fines
• Need for speed to market with new products
• Large sector
• Pharma,Med device, Biotech, CRO and related
  contractors

8
Business Drivers

• Consistent Approach to Regulatory Compliance
  Across the Full Enterprise
• Make Compliance Easier Through Integration of
  Compliance Best Practices in Normal Business
  Operations
• Deliver New Products to Market Faster
• Reduce New Product Development Cycle Times
• Decrease Regulatory Compliance Risk
• Improve Delivery of Regulated Content Across the
  Enterprise
• Decrease Cost of Compliance

9
The QUMAS Difference
10
Qumas History

• 1995 - founded
• 1997 - first round funding
• 1999 - second round funding
• 2000 - key breakthrough clients Merck, JJ
  turnover doubles
• 2001 - third funding round and turnover doubles
• 2002 - focus on new products and strong
  profitability

11
Financial Backers!

• Delta Partners
• Enterprise Ireland
• ACT Ventures
• AIB Ventures
• Accenture Ventures
• BOI Ventures
• CIBC Canada
• Private US Investors
• Stake Holders Execs

12
Worldwide Executive TEAM

• Brian Sweeney, Chairman
• Paul Hands, Co-Founder Chief Executive Officer
• David Grimes, Co-Founder Chief Operating
  Officer
• Michael Hennessy, Chief Financial Officer
• Kevin OLeary, President Qumas Inc, Global
  Alliances
• David Cronin, Director Global Sales
• Valarie King-Bailey, Chief Marketing Officer
• Sean Griffin, VP Research
• Nigel Porter, VP Development
• Kevin Fitzgerald VP EU Sales
• Jeff Sager, VP US Sales

13
Awards Honors

• Ranked in Global Software 500
• Deloitte Touche Fast 50
• Deloitte Touche Fast 500 EU
• Top 10 indigenous Software Exporter 2001
• Runner-up Company of the Year 2001,2
• Runner-up Marketing innovation 2001,2

14
2002 Frost Sullivan Market Engineering Award

• Frost Sullivan recognizes outstanding industry
  achievements by presenting Market Engineering
  Awards to top companies in a variety of regional
  and global markets
• QUMAS Received
• Life Sciences Vertical Market Penetration
  Award
• 26 Global Market Share

15
Qumas Locations

• Cork, Ireland
• RD Centre
• Services Support Centre
• Finance, Admin,IT, HR
• EU Sales and Marketing
• Florham Park, New Jersey
• US Sales Office
• US Services Support
• Chicago
• Global Marketing

16
Strong Client Base

• Merck
• JJ
• Roche
• Astra Zeneca
• Baxter
• Hollister
• over 100 clients in total

17
QUMAS Technology Partners
US DATA MANAGEMENT
18
MARKET VALUE DYNAMICS

• Capture value through strategic corporate
  planning
• Learn from and co-operate with the Market
• Market assessment sets VALUE
• Strategy aligned to the fluid nature of The
  Environment
• Alliances
• Manage like a Adventure Capitalist.
• Understanding the Value creation milestones
• Setting and continually monitoring internal and
  external milestones against market expectations

19
MARKET VALUE DYNAMICS

• Greatest leaps in value achieved through
• Removal of major uncertainties over commercial
  success!
• Client acceptance
• Market size validation
• Competitive performance
• Quality of management team
• Proven performance

20
ANY QUESTIONS